Verona Pharma (VRNA)

AI Score

Unlock

65.89

-3.74 (-5.37%)

At close: Mar 03, 2025, 3:59 PM

68.49

3.94%

After-hours: Mar 03, 2025, 07:46 PM EST

Verona Pharma Balance Sheet Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Cash & Equivalents	399.76M	271.77M	227.83M	148.38M	187.99M	30.07M	25.1M	42.49M	49.09M	5.22M	15.52M	995.65K	1.55M	3.92M	3.09M	4.58M	3.6M	2.48M	2.08M	1.69M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	10.26M	57M	65.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.55M	n/a
Long-Term Investments	n/a	15M	15M	15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.45	0.04	1.01	0.59	0.39	0.00	n/a
Other Long-Term Assets	18.08M	n/a	15.07M	15.08M	n/a	n/a	n/a	1.00	n/a	n/a	n/a	1.00	n/a	-3.92M	-3.09M	-4.58M	-3.6M	-2.48M	-2.08M	n/a
Receivables	31.5M	10.95M	9.28M	15.58M	8.26M	n/a	7.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	477.94K	n/a	n/a
Inventory	6.25M	1.00	2.5M	4.04M	4.54M	3.51M	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	-141.29K	-106.49K	-616.08K	-99.58K	-477.94K	n/a	-3.44K
Other Current Assets	16.07M	6.98M	5.89M	6.1M	6.26M	13.49M	8.47M	9.21M	4.97M	2.05M	2.37M	249.64K	336.21K	141.07K	106.49K	616.08K	99.58K	477.94K	103.84K	15.49K
Total Current Assets	453.57M	289.71M	243M	170.06M	202.5M	53.66M	90.94M	117.68M	54.05M	8.26M	17.52M	1.41M	1.89M	4.06M	3.2M	5.19M	3.69M	2.96M	4.73M	1.71M
Property-Plant & Equipment	2.05M	2.87M	927K	979K	1.16M	1.33M	26.65K	21.62K	17.07K	20.48K	34K	45.59K	63.81K	9.32K	23.15K	29.11K	20.5K	31.73K	33.31K	n/a
Goodwill & Intangibles	545K	545K	545K	545K	545K	4.19M	3.27M	3.26M	2.86M	2.69M	2.88M	2.76M	2.58M	2.46M	2.42M	2.49M	2.26M	3.05M	3M	n/a
Total Long-Term Assets	20.67M	18.42M	16.47M	16.52M	1.7M	5.52M	3.29M	3.28M	2.88M	2.71M	2.91M	2.81M	2.64M	2.47M	2.45M	2.52M	2.28M	3.08M	3.03M	1.69M
Total Assets	474.24M	308.12M	259.47M	186.59M	204.21M	59.18M	94.23M	120.96M	56.93M	10.96M	20.43M	4.22M	4.53M	6.53M	5.64M	7.71M	5.97M	6.04M	7.77M	1.71M
Account Payables	11.27M	3.49M	2.91M	10.04M	178K	1.93M	3.6M	1.21M	719K	1.9M	570.64K	543.77K	219.18K	138.19K	219.16K	189.19K	71.75K	194.35K	66.61K	20.65K
Deferred Revenue	n/a	n/a	n/a	22.4M	10.86M	-0.00	106.00	152K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.12M	1.18M	675K	648K	1.6M	611K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	21.41M	4.02M	15.16M	22.58M	12.43M	10.07M	9.37M	10.17M	12.54M	786.37K	245.44K	263.12K	102.93K	104.01K	98.78K	274.89K	51.26K	117K	62.69K	n/a
Total Current Liabilities	42.68M	8.69M	19.03M	33.42M	14.2M	12.61M	12.97M	11.62M	13.41M	2.69M	816.08K	806.89K	322.11K	242.21K	317.94K	464.08K	123.01K	311.35K	129.31K	20.65K
Long-Term Debt	1.24M	50.15M	9.97M	5.16M	5.15M	492.19K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	225.76M	n/a	n/a	n/a	n/a	159.81K	1.26M	1.18M	989.76K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	227M	50.15M	9.97M	5.16M	5.15M	2.17M	1.4M	1.39M	989.76K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	269.68M	58.84M	29M	38.58M	19.35M	14.78M	14.37M	13M	14.4M	2.69M	816.08K	806.89K	322.11K	242.21K	317.94K	464.08K	123.01K	311.35K	129.31K	20.65K
Total Debt	2.36M	51.33M	10.65M	5.81M	5.95M	1.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	43.36M	42.77M	40.53M	31.86M	31.79M	6.9M	6.68M	7.1M	3.17M	1.5M	1.57M	614.41K	496.44K	444.04K	370.42K	375.14K	314.85K	291.52K	282.13K	86.03K
Retained Earnings	-562.4M	-388.43M	-333.1M	-263.72M	-207.05M	-131.94M	-87.7M	-66.56M	-35.44M	-34.22M	-24.49M	-21.65M	-17.16M	-12.75M	-10.07M	-7.55M	-4.64M	-3.57M	-1.14M	44.74K
Comprehensive Income	-4.6M	-4.6M	-4.6M	-4.6M	-4.6M	11.45M	n/a	n/a	-3.9K	-132.9K	-124.28K	-114.06K	-101.44K	793.38K	554.08K	577.27K	502.29K	803.17K	-1.96K	n/a
Shareholders Equity	204.56M	249.28M	230.47M	148M	184.85M	44.4M	79.86M	107.95M	42.53M	8.28M	19.62M	3.41M	4.21M	6.29M	5.33M	7.25M	5.85M	5.73M	7.64M	1.68M
Total Investments	n/a	15M	15M	15M	n/a	10.26M	57M	65.97M	n/a	n/a	n/a	n/a	n/a	0.45	0.04	1.01	0.59	0.39	2.55M	n/a